These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17613006)

  • 1. Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation.
    Morales PR; Dillehay DL; Moody SJ; Pallas DC; Pruett S; Allgood JC; Symolon H; Merrill AH
    Drug Chem Toxicol; 2007; 30(3):197-216. PubMed ID: 17613006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in rat hepatic cytolethality of the protein kinase C inhibitor safingol: role of biotransformation.
    Carfagna MA; Young KM; Susick RL
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):173-81. PubMed ID: 8661342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the unnatural anticancer lipid safingol, L-threo-dihydrosphingosine, in cultured cells.
    Dragusin M; Gurgui C; Schwarzmann G; Hoernschemeyer J; van Echten-Deckert G
    J Lipid Res; 2003 Sep; 44(9):1772-9. PubMed ID: 12777464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.
    Mazzoleni S; Jachetti E; Morosini S; Grioni M; Piras IS; Pala M; Bulfone A; Freschi M; Bellone M; Galli R
    Stem Cells Transl Med; 2013 Sep; 2(9):678-89. PubMed ID: 23884639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents.
    Kedderis LB; Bozigian HP; Kleeman JM; Hall RL; Palmer TE; Harrison SD; Susick RL
    Fundam Appl Toxicol; 1995 May; 25(2):201-17. PubMed ID: 7665004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA; Narayanan NK; Pttman B; Reddy BS
    Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.
    Kang BH; Tavecchio M; Goel HL; Hsieh CC; Garlick DS; Raskett CM; Lian JB; Stein GS; Languino LR; Altieri DC
    Br J Cancer; 2011 Feb; 104(4):629-34. PubMed ID: 21285984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
    Ronca R; Alessi P; Coltrini D; Di Salle E; Giacomini A; Leali D; Corsini M; Belleri M; Tobia C; Garlanda C; Bonomi E; Tardanico R; Vermi W; Presta M
    J Pathol; 2013 Jun; 230(2):228-38. PubMed ID: 23424081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway.
    Coward J; Ambrosini G; Musi E; Truman JP; Haimovitz-Friedman A; Allegood JC; Wang E; Merrill AH; Schwartz GK
    Autophagy; 2009 Feb; 5(2):184-93. PubMed ID: 19098447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.
    Schwartz GK; Ward D; Saltz L; Casper ES; Spiess T; Mullen E; Woodworth J; Venuti R; Zervos P; Storniolo AM; Kelsen DP
    Clin Cancer Res; 1997 Apr; 3(4):537-43. PubMed ID: 9815717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.
    Venier NA; Yamamoto T; Sugar LM; Adomat H; Fleshner NE; Klotz LH; Venkateswaran V
    Prostate; 2015 Sep; 75(12):1300-11. PubMed ID: 26047020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS
    Cancer Res; 2000 Aug; 60(15):4093-7. PubMed ID: 10945615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest.
    Cho HJ; Lim DY; Kwon GT; Kim JH; Huang Z; Song H; Oh YS; Kang YH; Lee KW; Dong Z; Park JH
    Int J Mol Sci; 2016 Feb; 17(2):264. PubMed ID: 26907265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
    Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
    Front Immunol; 2020; 11():1820. PubMed ID: 33013832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.
    Ru P; Steele R; Nerurkar PV; Phillips N; Ray RB
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2122-30. PubMed ID: 21911444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia.
    Tan KB; Ling LU; Bunte RM; Chng WJ; Chiu GN
    J Control Release; 2012 Jun; 160(2):290-8. PubMed ID: 22100388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial.
    Bullock MJ; Srigley JR; Klotz LH; Goldenberg SL
    Am J Surg Pathol; 2002 Nov; 26(11):1400-13. PubMed ID: 12409716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate.
    Morey Kinney SR; Zhang W; Pascual M; Greally JM; Gillard BM; Karasik E; Foster BA; Karpf AR
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1065-75. PubMed ID: 19934341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.